14th Jan 2016 09:45
LONDON (Alliance News) - Microbiological control technologies company Bioquell PLC on Thursday said trading in the second half of 2015 was in line with its expectations.
The company, which focuses on decontamination and infection control technology, said revenue for the year to the end of December is set to be marginally lower at GBP27.0 million against GBP27.3 million.
Life sciences revenue rose 1.8% in the year, boosted by a strong second half, but healthcare revenue fell 2.2% and defence revenue dropped 14%.
Pretax profit before one-offs will meet expectations, the company said, but it will book a GBP200,000 charge related to job cuts made in the fourth quarter.
Bioquell shares were down 1.0% to 137.15 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Bioquell